AAV.7m8
Showing 1 - 25 of >10,000
Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of
Active, not recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- 6E11 vg/eye of ADVM-022
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 10, 2022
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +10 more
Mar 21, 2022
Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Recruiting
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Phoenix, Arizona
- +4 more
Sep 8, 2022
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Enrolling by invitation
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +8 more
Dec 23, 2021
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Achromatopsia Trial in Ann Arbor, London (either AAV - CNGB3 or AAV - CNGA3)
Active, not recruiting
- Achromatopsia
- either AAV - CNGB3 or AAV - CNGA3
-
Ann Arbor, Michigan
- +1 more
Jan 13, 2022
Achromatopsia Trial in Ann Arbor, London (adeno-associated virus vector AAV- CNGA3)
Completed
- Achromatopsia
- adeno-associated virus vector AAV- CNGA3
-
Ann Arbor, Michigan
- +1 more
Feb 10, 2022
Hemophilia B, Hemophilia A Trial in Worldwide (Standard of Care FIX Replacement therapy, Standard of Care FVIII Replacement
Recruiting
- Hemophilia B
- Hemophilia A
- Standard of Care FIX Replacement therapy
- Standard of Care FVIII Replacement therapy
-
Palo Alto, California
- +77 more
Dec 29, 2022
OTC Deficiency Trial in Worldwide (genetic, other, drug)
Recruiting
- OTC Deficiency
- DTX301
- +4 more
-
Aurora, Colorado
- +19 more
Jul 29, 2022
Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))
Suspended
- Infection
- Fecal Microbiota Transplantation (FMT)
-
Brampton, Ontario, Canada
- +12 more
Nov 1, 2022
The Impact of Opioid and Cannabis Exposure on Fetal Growth
Recruiting
- Pregnancy Related
- +3 more
-
Hamilton, Ontario, Canada
- +4 more
Jun 2, 2023
Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))
Completed
- Hemangioma
- Kaposiform Hemangioendothelioma
-
Shanghai, ChinaChildren's Hospital of Fudan University
Jan 27, 2023
Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)
Enrolling by invitation
- Choroideremia
- X-Linked Retinitis Pigmentosa
- BIIB111
- BIIB112
-
Los Angeles, California
- +22 more
Apr 20, 2022
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
-
Gilbert, Arizona
- +4 more
Dec 6, 2022
Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)
Completed
- Osteoarthritis
- ATB-346 low dose
- +3 more
-
Mission, British Columbia, Canada
- +34 more
Jul 20, 2022
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:
Not yet recruiting
- EBV-Related Hodgkin Lymphoma
- +2 more
- Dose Level 1A: 2 x 10^7 cells/m2
- +4 more
-
Houston, Texas
- +1 more
Feb 7, 2022
Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)
Active, not recruiting
- Cancer
- +2 more
- Tranexamic acid (TXA)
- Normal saline
-
Rochester, Minnesota
- +10 more
Oct 25, 2022
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022
Choroideremia Trial in Worldwide (BIIB111)
Completed
- Choroideremia
- BIIB111
-
Los Angeles, California
- +17 more
Dec 1, 2021